AUGUST 2024LIFE SCIENCES REVIEW6A growing demand for biomaterials in wound healing and plastic surgery procedures is fueling the biomaterials market's expansion. Rising investments in regenerative and personalized medicine are also creating exciting opportunities for novel biomaterial applications. Further propelling the market is the increasing use of biomaterials across various therapeutic areas and the ever-growing demand for implantable medical devices. The global biomaterials market was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3 percent in the forecast period.Driven by a rising need to avoid unnecessary costs, patient discomfort, and potential surgical complications, there is a growing interest in bio-absorbable biomaterials, which are designed to dissolve within the body over time. Smart and antimicrobial biomaterials are another trending topic, as these materials are responsive to their environment, meaning they can adapt to changes in temperature, pressure, or biological signals. This opens doors for controlled drug delivery, tissue regeneration that mimics natural healing processes, and biomaterials that can integrate more seamlessly with the body and improve implant longevity.This edition of Life Sciences Review Europe delves into the recent developments in the biomaterials processing space and how companies can leverage innovative advancements in the sector to enhance their offerings. It features thought leadership articles from Jessica Wilson Rayse, associate director of product management, Accugenix at Charles River Laboratories and Xavier Salas, corporate legal & compliance manager at Neuraxpharm. Rayse highlights the importance of understanding microbial presence in the manufacturing environment and posits control measures to ensure a sterile product. Salas emphasizes the importance of strict liability standards for manufacturers and the necessity of enhanced safety protocols, increased risk assessment measures and a greater emphasis on post-marketing surveillance for medical products.In this edition, featuring the top biomaterials processing companies in Europe 2024, we hope you'll find the ideal partner to serve your biomaterial processing needs and elevate your services to offer innovative healthcare solutions.Let us know your thoughts!EDITORIALThe Next Generation of BiomaterialsCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com AUGUST - 26 - 2024, Vol 05, Issue - 24 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsHenry SmithClara Matthew
< Page 5 | Page 7 >